title: Antitumour necrosis factor-alpha antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis.
authors.forename: M
authors.initials: M
authors.lastname: Fischer
authors.forename: E
authors.initials: E
authors.lastname: Fiedler
authors.forename: W C
authors.initials: WC
authors.lastname: Marsch
authors.forename: J
authors.initials: J
authors.lastname: Wohlrab
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D013262:Stevens-Johnson Syndrome / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab